Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 152.00
+1.50 (1.00%)
Sep 10, 2026, 5:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 23.78 million as of September 11, 2026. Its market cap has decreased by -35.22% in one year.
Market Cap
23.78M
Enterprise Value
29.27M
Revenue
4.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
152.00
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 23.78M, a decrease of -78.98%. That is a compound annual growth rate of -7.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 23.78M | -9.24% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 202.09M |
| Matricelf | 80.79M |
| Clal Biotechnology Industries | 40.31M |
| BioLineRx | 34.07M |
| BioLight Life Sciences | 26.35M |
| XTL Biopharmaceuticals | 25.16M |
| Purple Biotech | 18.65M |
| Can-Fite BioPharma | 14.84M |